These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. White matter changes in paediatric multiple sclerosis and monophasic demyelinating disorders. Longoni G; Brown RA; MomayyezSiahkal P; Elliott C; Narayanan S; Bar-Or A; Marrie RA; Yeh EA; Filippi M; Banwell B; Arnold DL; Brain; 2017 May; 140(5):1300-1315. PubMed ID: 28334875 [TBL] [Abstract][Full Text] [Related]
23. Patterning Chronic Active Demyelination in Slowly Expanding/Evolving White Matter MS Lesions. Elliott C; Arnold DL; Chen H; Ke C; Zhu L; Chang I; Cahir-McFarland E; Fisher E; Zhu B; Gheuens S; Scaramozza M; Beynon V; Franchimont N; Bradley DP; Belachew S AJNR Am J Neuroradiol; 2020 Sep; 41(9):1584-1591. PubMed ID: 32819894 [TBL] [Abstract][Full Text] [Related]
24. Low degree of cortical pathology is associated with benign course of multiple sclerosis. Calabrese M; Favaretto A; Poretto V; Romualdi C; Rinaldi F; Mattisi I; Morra A; Perini P; Gallo P Mult Scler; 2013 Jun; 19(7):904-11. PubMed ID: 23069877 [TBL] [Abstract][Full Text] [Related]
25. Brain lesion location and clinical status 20 years after a diagnosis of clinically isolated syndrome suggestive of multiple sclerosis. Dalton CM; Bodini B; Samson RS; Battaglini M; Fisniku LK; Thompson AJ; Ciccarelli O; Miller DH; Chard DT Mult Scler; 2012 Mar; 18(3):322-8. PubMed ID: 21878451 [TBL] [Abstract][Full Text] [Related]
26. A patient with established primary progressive multiple sclerosis transitions to 'secondary' relapsing-remitting disease course following a fulminant demyelinating episode. Tutuncu M; Demirci NO; Özer F; Saip S; Kantarci OH; Siva A Mult Scler; 2011 Oct; 17(10):1262-4. PubMed ID: 21135019 [TBL] [Abstract][Full Text] [Related]
27. Proliferating oligodendrocytes are present in both active and chronic inactive multiple sclerosis plaques. Solanky M; Maeda Y; Ming X; Husar W; Li W; Cook S; Dowling P J Neurosci Res; 2001 Aug; 65(4):308-17. PubMed ID: 11494366 [TBL] [Abstract][Full Text] [Related]
28. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study. Tedeschi G; Dinacci D; Comerci M; Lavorgna L; Savettieri G; Quattrone A; Livrea P; Patti F; Morra VB; Servillo G; Orefice G; Paciello M; Prinster A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Brunetti A; Salemi G; D'Amelio M; Simone I; Salvatore M; Bonavita V; Alfano B Mult Scler; 2009 Feb; 15(2):204-11. PubMed ID: 18987104 [TBL] [Abstract][Full Text] [Related]
29. Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions. Elliott C; Wolinsky JS; Hauser SL; Kappos L; Barkhof F; Bernasconi C; Wei W; Belachew S; Arnold DL Mult Scler; 2019 Dec; 25(14):1915-1925. PubMed ID: 30566027 [TBL] [Abstract][Full Text] [Related]
30. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis. Papadopoulou A; Müller-Lenke N; Naegelin Y; Kalt G; Bendfeldt K; Kuster P; Stoecklin M; Gass A; Sprenger T; Radue EW; Kappos L; Penner IK Mult Scler; 2013 Sep; 19(10):1290-6. PubMed ID: 23459568 [TBL] [Abstract][Full Text] [Related]
31. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis. Di Perri C; Battaglini M; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N Arch Neurol; 2008 Feb; 65(2):236-43. PubMed ID: 18268194 [TBL] [Abstract][Full Text] [Related]
32. Cellular distribution of glucose and monocarboxylate transporters in human brain white matter and multiple sclerosis lesions. Nijland PG; Michailidou I; Witte ME; Mizee MR; van der Pol SM; van Het Hof B; Reijerkerk A; Pellerin L; van der Valk P; de Vries HE; van Horssen J Glia; 2014 Jul; 62(7):1125-41. PubMed ID: 24692237 [TBL] [Abstract][Full Text] [Related]
33. Pathology of multiple sclerosis and related inflammatory demyelinating diseases. Kutzelnigg A; Lassmann H Handb Clin Neurol; 2014; 122():15-58. PubMed ID: 24507512 [TBL] [Abstract][Full Text] [Related]
34. Gender-related differences in MS: a study of conventional and nonconventional MRI measures. Antulov R; Weinstock-Guttman B; Cox JL; Hussein S; Durfee J; Caiola C; Dwyer MG; Bergsland N; Abdelrahman N; Stosic M; Hojnacki D; Munschauer FE; Miletic D; Zivadinov R Mult Scler; 2009 Mar; 15(3):345-54. PubMed ID: 19028830 [TBL] [Abstract][Full Text] [Related]
35. Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome. Kantarci OH; Lebrun C; Siva A; Keegan MB; Azevedo CJ; Inglese M; Tintoré M; Newton BD; Durand-Dubief F; Amato MP; De Stefano N; Sormani MP; Pelletier D; Okuda DT Ann Neurol; 2016 Feb; 79(2):288-94. PubMed ID: 26599831 [TBL] [Abstract][Full Text] [Related]
36. Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron. Haider L; Simeonidou C; Steinberger G; Hametner S; Grigoriadis N; Deretzi G; Kovacs GG; Kutzelnigg A; Lassmann H; Frischer JM J Neurol Neurosurg Psychiatry; 2014 Dec; 85(12):1386-95. PubMed ID: 24899728 [TBL] [Abstract][Full Text] [Related]
37. Characteristics of lesional and extra-lesional cortical grey matter in relapsing-remitting and secondary progressive multiple sclerosis: A magnetisation transfer and diffusion tensor imaging study. Yaldizli Ö; Pardini M; Sethi V; Muhlert N; Liu Z; Tozer DJ; Samson RS; Wheeler-Kingshott CA; Yousry TA; Miller DH; Chard DT Mult Scler; 2016 Feb; 22(2):150-9. PubMed ID: 26014608 [TBL] [Abstract][Full Text] [Related]
38. Investigation of outer cortical magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups. Samson RS; Cardoso MJ; Muhlert N; Sethi V; Wheeler-Kingshott CA; Ron M; Ourselin S; Miller DH; Chard DT Mult Scler; 2014 Sep; 20(10):1322-30. PubMed ID: 24552746 [TBL] [Abstract][Full Text] [Related]